These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Mar 5, 2014
Ludwig Cancer Research and Agenus Inc. (NASDAQ: AGEN) today announced the selection of three monoclonal antibody checkpoint modulators (CPMs) that Agenus is advancing into preclinical development....
Feb 27, 2014Agenus to Report Fourth Quarter and Year End 2013 Financial Results on March 5, 2014; Conference Call to Follow
Agenus Inc. (NASDAQ: AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. Agenus executives will host a conference call at 11:00 a.m....
Feb 13, 2014Agenus gains powerful platform for rapid discovery and optimization of fully-human antibodies against a wide array of molecular targets
Agenus Inc. (Nasdaq: AGEN), a biopharmaceutical company developing novel immunotherapeutics, including a portfolio of checkpoint modulators (CPMs), anti-cancer vaccines and adjuvants, today...
Feb 10, 2014
Agenus Inc. (Nasdaq: AGEN) today announced the closing of its previously announced underwritten registered public offering of common stock. The total number of shares of common stock sold was...
Feb 6, 2014
Agenus Inc. (Nasdaq: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, today announced that the company will be presenting at...